Перейти к содержимому
RU
Красота2AIОт идеи до готового продукта.

SUBTILISIN

舒替兰酶

CAS 9014-01-1EC 232-752-2PubChem CID 57078918

KERATOLYTICУВЛАЖНЕНИЕ КОЖИIrritancy 3/5 · Comedogenic –/5Ритуал ухода

Что это и как применяется

Protease enzyme for gentle exfoliation by breaking down dead skin. Strictly control concentration and contact time; excessive use may compromise the barrier.

Статус в национальных реестрах

Китай · Список имеющихся ингредиентов06184rinse-off 6% · leave-on 5%
ЕС · CosIng79312功能 KERATOLYTIC, SKIN CONDITIONING

Совпадение по точному названию INCI; соли, эфиры и синонимы могут быть пропущены. Приоритет у последнего официального текста.

Regulatory status by market Prohibited / restricted / permitted — listing is not approval

Asia-Pacific

РынокStatusConditions (as published)Источник
AustraliaAICIS / TGARestrictedAICIS Inventory terms of listing
CR No.: 12086 | CAS No: 9014-01-1 | Specific Information Requirements: Obligations to provide information apply. These obligations are: 1. If the assessment rep… Show full text

CR No.: 12086 | CAS No: 9014-01-1 | Specific Information Requirements: Obligations to provide information apply. These obligations are: 1. If the assessment report about the chemical recommends secondary notification of the chemical in particular circumstances and any of the circumstances occur in relation to the introduction (importation or manufacture) of the chemical by a person, then the person introducing this chemical must tell us in writing within 28 calendar days that the circumstances have occurred. 2. A person who introduces this chemical must tell us in writing within 28 calendar days if they become aware of any of the following circumstances, namely, that since the assessment under the Industrial Chemicals (Notification and Assessment) Act 1989: a. the function or use of the chemical has changed, or is likely to change, significantly; b. the amount of the chemical being introduced has increased, or is likely to increase, significantly; c. in the case of a chemical not manufactured, or proposed to be manufactured, in Australia at the time of the assessment—it has begun to be manufactured in Australia; d. the method of manufacture of the chemical in Australia has changed, or is likely to change, in a way that may result in an increased risk of an adverse effect of the chemical on occupational health and safety, public health or the environment; e. additional information has become available to the person as to an adverse effect of the chemical on occupational health and safety, public health or the environment.

au-aicisC · Official source

Public regulatory text on file for 1 jurisdiction(s), covering 1 countries / territories once regional blocs are expanded. Other markets have no public data here — absence is neither approval nor prohibition. Table updated 2026-09-22.

Compiled from publicly published regulatory texts; conditions are reproduced as published, neither rewritten nor translated. The latest official announcement of the target market prevails — this table is a compiled reference, not a compliance conclusion. Matched on the INCI name; salts, esters and synonyms may be missed. Usability and labelling are for the brand and its responsible person to verify against the full text.

Популярные продукты с этим ингредиентом 12 products

Функции из EU CosIng и реестра Китая; раздражающий потенциал, комедогенность и оценка — внутренняя интерпретация, не регуляторный вывод. Структурные и молекулярные данные из PubChem.

Хотите работать с этим ингредиентом? Отправьте запрос